1. Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. Lupus nephritis: A critical review. Autoimmun Rev 2012;12:174-94.
2. Bastian HM, Roseman JM, Mcgwin G, Alarcón GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002;11:152-60.
3. Plantinga L, Lim SS, Patzer R, McClellan W, Kramer M, Klein M, et al. Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry: ESRD Incidence in SLE Patients. Arthritis Care Res 2016;68:357-65.
4. Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: Results from an international inception cohort study. Rheumatology Oxford 2016;55:252-62.
5. Kono M, Yasuda S, Kato M, Kanetsuka Y, Kurita T, Fujieda Y, et al. Long-term outcome in Japanese patients with lupus nephritis. Lupus 2014;23:1124-32.
6. Misra R, Gupta R. Biomarkers in lupus nephritis. Int J Rheum Dis 2015;18:219-32.
7. Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol 2017;185:10-20.
8. Adhya Z, Borozdenkova S, Karim MY. The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis. Nephrol Dial Transplant 2011;26:3273-80.
9. Hutcheson J, Ye Y, Han J, Arriens C, Saxena R, Li Q-Z, et al. Resistin as a potential marker of renal disease in lupus nephritis: An adipokine marker in lupus nephritis. Clin Exp Immunol 2015;179:435-43.
10. Chen D-Y, Chen Y-M, Wen M-C, Hsieh T-Y, Hung W-T, Lan J-L. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus 2012;21:1385-96.
11. Diaz-Rizo V, Bonilla-Lara D, Gonzalez-Lopez L, Sanchez-Mosco D, Fajardo-Robledo NS, Perez-Guerrero EE, et al. Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis 2017;12:e0184056. doi:10.1371/journal.pone.0184056
12. Lang T, Foote A, Lee JPW, Morand EF, Harris J. MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus. Front Immunol 2015;6:577.
13. Otukesh H, Chalian M, Hoseini R, Chalian H, Hooman N, Bedayat A, et al. Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus. Clin Rheumatol 2007;26:2105-7.
14. Vincent FB, Slavin L, Hoi AY, Kitching AR, Mackay F, Harris J, et al. Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus. Lupus Sci Med 2018;5:e000277. doi:10.1136/lupus-2018-000277
15. Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, et al. Increased Plasma Concentration of Macrophage Migration Inhibitory Factor (MIF) and MIF mRNA in Mononuclear Cells in the Obese and the Suppressive Action of Metformin. J Clin Endocrinol Metab 2004;89:5043-7.
16. Koska J, Stefan N, Dubois S, Trinidad C, Considine RV, Funahashi T, et al. mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int J Obes 2009;33:842-50.
17. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Sánchez-Serrano C. Mestizaje e historia de la población en México. Madrid, España: Real Academia de Ciencias Exactas Físicas y Naturales; 1996. p. 173–193
19. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Sanchez-Guerrero J, et al. The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
20. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin A, et al. Derivation of the sledai. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
21. Guzmán J, Cardiel MH, Arce-Salinas A, Sánchez-Guerrero J, Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992;19:1551-8.
22. McClelland GH, Irwin JR, Disatnik D, Sivan L. Multicollinearity is a red herring in the search for moderator variables: A guide to interpreting moderated multiple regression models and a critique of Iacobucci, Schneider, Popovich, and Bakamitsos (2016). Behav Res Methods 2017;49:394-402.
23. Eberly LE. Multiple Linear Regression. In: Ambrosius WT editors. Topics in Biostatistics. Methods in Molecular Biology. Humana Press; 2007. p 165-187
24. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. Available from: https://www.R-project.org/
25. Wickham H. ggplot2: Elegant Graphics for Data Analysis (Use R!). Springer International Publishing; 2016.
26. Jorge Medina-Rosas, Zahi Touma. Proteinuria: Assessment and Utility in Lupus Nephritis. Orthop Res Physiother 2016;2:1-8.
27. Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM, et al. Urine Macrophage Migration Inhibitory Factor Reflects the Severity of Renal Injury in Human Glomerulonephritis. J Am Soc Nephrol. 2002;13 Suppl 1:S7-S13.
28. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
29. Leech M, Metz C, Bucala R, Morand EF. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum 2000;43:827-33.
30. Kang I, Bucala R. The immunobiology of MIF: function, genetics and prospects for precision medicine. Nat Rev Rheumatol 2019;15:427-37.
31. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognised source of macrophage migration inhibitory factor. J Exp Med 1994;17:1895-902.
32. Ouedraogo R, Wu X, Xu S-Q, Fuchsel L, Motoshima H, Mahadev K, et al. Adiponectin Suppression of High-Glucose-Induced Reactive Oxygen Species in Vascular Endothelial Cells: Evidence for Involvement of a cAMP Signaling Pathway. Diabetes 2006;55:1840-6.
33. Declèves A-E, Mathew AV, Cunard R, Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol JASN 2011;22:1846-55.
34. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Muñoz EG, Salazar-Paramo M, González-Ortiz M, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 2002;22:138-41.
35. Chen H, Shi B, Feng X, Kong W, Chen W, Geng L, et al. Leptin and Neutrophil-Activating Peptide 2 Promote Mesenchymal Stem Cell Senescence Through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol 2015;67:2383-93.
36. Elshishtawy H, Ibrahim SE, Helmi A, Farouk N, Elshinnawy MA. Resistin in systemic lupus erythematosus: Relation to lupus nephritis and premature atherosclerosis. Egypt Rheumatol 2012;34:137-46.
37. Baker JF, Morales M, Qatanani M, Cucchiara A, Nackos E, Lazar MA, et al. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification. J Rheumatol 2011;38:2369-75.
38. Lee YH, Song GG. Association between circulating leptin levels and systemic lupus erythematosus: an updated meta-analysis. Lupus 2018;27:428-35.
39. Li H, Zhang T, Leng R, Li X, Li X, Pan H. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis. Arch Med Res 2015;46:551-6.
40. Huang Q, Tao S-S, Zhang Y-J, Zhang C, Li L-J, Zhao W, et al. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 2015;34:1713-20.
41. Santos FMM, Telles RW, Lanna CCD, Teixeira AL, Miranda AS, Rocha NP, et al. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus. Lupus 2017;26:10-6.
42. Roger T, Chanson A-L, Knaup-Reymond M, Calandra T. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 2005;35:3405-13.